The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes
Risk stratification and prognostication are crucial for the appropriate management of patients with myelodysplastic syndromes myelodysplastic syn
Myelodysplastic Syndromes (MDS)
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53
The genetic underpinnings of myeloid neoplasms are becoming increasingly well understood.
Transfusion Support of Patients with Myelodysplastic Syndromes
Patients with MDS often suffer from anemia anemia: (uh-NEE-mee-uh) A condition in which there is a shortage of red blood cells in the bloodstream. This causes a low red blood cell count.
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists
The diagnosis of myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorde
Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes
Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone
Morphologic Characteristics of Myelodysplastic Syndromes
Morphologic characterization remains a cornerstone in the diagnosis and classification of myelodysplastic syndromes myelodysplastic syndromes
Clinical decision-making and treatment of myelodysplastic syndromes
The myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the
Diagnosis and classification of myelodysplastic syndromes
Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone
2023 ASH Update - MDS and AML
Topic(s)
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
In this webinar, Dr. Akriti Jain will explains the latest research presented the American Society of Hematology meeting on MDS and secondary AML. This is an advanced presentation.